Molecular genetics of prostate cancer: new prospects for old challenges

MM Shen, C Abate-Shen - Genes & development, 2010 - genesdev.cshlp.org
Despite much recent progress, prostate cancer continues to represent a major cause of
cancer-related mortality and morbidity in men. Since early studies on the role of the …

The impact of translocations and gene fusions on cancer causation

F Mitelman, B Johansson, F Mertens - Nature Reviews Cancer, 2007 - nature.com
Chromosome aberrations, in particular translocations and their corresponding gene fusions,
have an important role in the initial steps of tumorigenesis; at present, 358 gene fusions …

The oncogene ERG: a key factor in prostate cancer

P Adamo, MR Ladomery - Oncogene, 2016 - nature.com
ETS-related gene (ERG) is a member of the E-26 transformation-specific (ETS) family of
transcription factors with roles in development that include vasculogenesis, angiogenesis …

Role of the TMPRSS2-ERG gene fusion in prostate cancer

SA Tomlins, B Laxman, S Varambally, X Cao, J Yu… - Neoplasia, 2008 - Elsevier
TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer.
Here, we explored the role of TMPRSS2-ERG gene fusion product using in vitro and in vivo …

Recurrent gene fusions in prostate cancer

C Kumar-Sinha, SA Tomlins, AM Chinnaiyan - Nature Reviews Cancer, 2008 - nature.com
The discovery of recurrent gene fusions in a majority of prostate cancers has important
clinical and biological implications in the study of common epithelial tumours. Gene fusion …

Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer

R Vatapalli, V Sagar, Y Rodriguez, JC Zhao… - Nature …, 2020 - nature.com
The histone methyltransferase DOT1L methylates lysine 79 (K79) on histone H3 and is
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical …

W Weichert, A Röske, V Gekeler, T Beckers… - British journal of …, 2008 - nature.com
High activity of histone deacetylases (HDACs) causes epigenetic alterations associated with
malignant cell behaviour. Consequently, HDAC inhibitors have entered late-phase clinical …

Identification of fusion genes in breast cancer by paired-end RNA-sequencing

H Edgren, A Murumagi, S Kangaspeska, D Nicorici… - Genome biology, 2011 - Springer
Background Until recently, chromosomal translocations and fusion genes have been an
underappreciated class of mutations in solid tumors. Next-generation sequencing …

Common gene rearrangements in prostate cancer

MA Rubin, CA Maher, AM Chinnaiyan - Journal of Clinical Oncology, 2011 - ascopubs.org
Prostate cancer is a common heterogeneous disease, and most patients diagnosed in the
post prostate-specific antigen (PSA) era present with clinically localized disease, the …

ETS gene fusions in prostate cancer: from discovery to daily clinical practice

SA Tomlins, A Bjartell, AM Chinnaiyan, G Jenster… - European urology, 2009 - Elsevier
CONTEXT: In 2005, fusions between the androgen-regulated transmembrane protease
serine 2 gene, TMPRSS2, and E twenty-six (ETS) transcription factors were discovered in …